A detailed history of Pinnacle Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Wealth Management, LLC holds 3,865 shares of VRTX stock, worth $1.88 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
3,865
Holding current value
$1.88 Million
% of portfolio
1.7%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$407.69 - $446.08 $1.58 Million - $1.72 Million
3,865 New
3,865 $1.62 Million
Q3 2023

Oct 19, 2023

BUY
$338.18 - $362.46 $28,745 - $30,809
85 Added 1.93%
4,494 $1.56 Million
Q2 2023

Aug 10, 2023

BUY
$314.42 - $351.91 $1.39 Million - $1.55 Million
4,409 New
4,409 $1.55 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $125B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pinnacle Wealth Management, LLC Portfolio

Follow Pinnacle Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Management, LLC with notifications on news.